BiotechTube
Home/CNBX Pharmaceuticals/Gabriel Yariv
GY

Gabriel Yariv

Executive Chairman of the Board

CNBX Pharmaceuticals

Therapeutic Areas

OncologyNeuropsychiatryGastroenterology

CNBX Pharmaceuticals Pipeline

DrugIndicationPhase
Cannabics® RCC-33Colorectal CancerPreclinical
Cannabics® MLN-33MelanomaPreclinical
Cannabics® BRST-33Breast CancerPreclinical
Cannabics® PRST-33Prostate CancerPreclinical
Cannabics® PLP-33Pre-cancerous PolypsPreclinical
Cannabics® SRCancer-related Anorexia Cachexia Syndrome (CACS)Phase 3
NP-01Neuropsychiatry (unspecified)Preclinical
NP-02Neuropsychiatry (unspecified)N/A

Leadership Team at CNBX Pharmaceuticals

EB
Eyal Barad
CEO, Board Member
UB
Uri Ben-Or
CFO
DS
Dr. Sanja Goldberg
CTO
DI
Dr. Ilya Reznik
Head of Neuropsychiatry Development
View full CNBX Pharmaceuticals profile